目的：探讨尿激酶溶栓治疗的时间窗。
Objective: To investigate the time window of urokinase thrombolysis.
使闭塞的脑血管再通是溶栓治疗的基础。
The foundation of thrombolytic therapy is reperfusion of the occluded artery.
溶栓治疗和抗凝治疗可有效改善患者预后。
Thrombolytic therapy and anti-coagulation could effective improve the prognosis of PE patients.
目的：探讨急性脑梗死溶栓治疗脑电图改变。
Objectives: To explore EEG changes of acute infarction treated by thrombolysis.
近年来的研究表明，溶栓治疗的时间窗应个体化。
The recent studies have shown that the therapeutic time window (TTW) for thrombolytic therapy should be individualized.
目的：了解尿激酶溶栓治疗对血小板功能的影响。
Objective:To observe the effect of thrombolytic therapy by urokinase (UK) on the function of platelet.
溶栓治疗是治疗血栓性疾病的安全而有效的手段。
Thrombolytic therapy is an effective tool for treatment of embolism.
急性缺血性卒中的溶栓治疗是目前医学研究的热点。
Thrombolytic therapy for acute ischemic stroke is a hotspot in current medical study.
约有半数的病人行溶栓治疗，半数病人行血管成形术。
About half of the patients were treated with thrombolytic therapy and half underwent angioplasty.
目的探讨骨折后急性下肢动脉血栓形成的溶栓治疗。
Objective To discuss the therapeutic method of thrombolysis of lower limbs after fracture.
及早诊断，行抗凝、溶栓治疗可防止肠坏死的发生。
Early diagnosis and active thrombolysis may help to prevent the intestinal necrosis.
方法对15例脑栓塞患者进行介入性动脉内溶栓治疗。
Methods: There were 15 cases cerebral embolism performed thrombolytic therapy by intervention.
方法对15例脑栓塞患者进行介入性动脉内溶栓治疗。
Methods There were 15 cases of cerebral embolism performed thrombolytic therapy by intervention.
早期抗凝和溶栓治疗对提高患者的生存率有明显的作用。
Early anti-coagulated and thrombosis-dissolved treatment can increase the survival rate of SMVT patients.
术后复发心肌缺血发生率较溶栓治疗和单纯PTCA低。
The recurrent ischemia rate was lower than thrombolysis and PTCA.
目的：探讨急性脑梗塞动脉内溶栓治疗的安全性和有效性。
Objective: To evaluate the safety and efficacy of intra-arterial fibrinolysis in acute cerebral infarction.
结论下肢深静脉血栓形成最好采取经浅静脉局部溶栓治疗。
Conclusions The best way in treating DVTLE is local thrombolysis via superficial vein medication.
溶栓治疗的方法包括静脉溶栓、动脉溶栓和动静脉联合溶栓。
The methods of thrombolytic therapy include intravenous thrombolysis, intra-arterial thrombolysis, and a combination of both.
目的评价血管内超声溶栓治疗急性外周动脉血栓形成的疗效。
Objective To evaluate intravascular ultrasonic thrombolysis in the treatment of acute peripheral arterial thrombosis.
结论低剂量尿激酶静脉溶栓治疗进展性脑梗死有效且相对安全。
Conclusion it is effective and safe for the patients with advanced cerebral infarction to get the treatment through intravenous thrombolysis with low-dose urokinase.
目的：评价急性脑梗死溶栓治疗与非溶栓治疗的疗效及经济成本。
Objective:To evaluate the effect and economic cost of thrombolytic therapy in acute cerebral infraction patients.
目的旨在探讨静脉溶栓治疗急性缺血性脑卒中的最佳治疗时间窗。
Objective To determine the most optional treatment time window for intravenous thrombolysis of acute ischemic stroke.
目的观察静脉注射尿激酶溶栓治疗急性脑梗死的临床疗效及安全性。
Aim To evaluate the clinical efficacy and safety of thrombolytic therapy for acute cerebral infarction.
结论动脉溶栓治疗脑梗塞，动脉内溶栓时间窗与多种因素密切相关。
Conclusion in treating acute cerebral infarction using intra-arterial thrombolysis, the therapeutic time window is closely related to a lot of factors.
结论：在急诊室内开展紧急静脉溶栓治疗急性心肌梗塞有效，安全。
Conclusion: it is effective and safe that therapy of AMI with intravenous thrombolysis at emergency department.
目的探讨经股动脉穿刺以尿激酶溶栓治疗糖尿病足的价值与安全性。
Objective To discuss the significance of urokinase thrombolysis via femoral artery puncture for the therapy of diabetic feet and its safety.
目的探讨经导管局部溶栓治疗肢体动脉闭塞疾病的疗效及影响因素。
Objective To evaluate the effect and influencing factors of transcatheter regional thrombolysis for limb arterial occlusion.
目的：评价国产尿激酶在急性心肌梗死溶栓治疗中的有效性和安全性。
Objective: To study the efficacy and safety with thrombolysis of urokinase produced in China on acute myocardial infarction.
所有病人中，35.7%单独接受溶栓治疗的病人随后再次接受pci。
Overall, 35.7% of those who received thrombolysis alone were subsequently referred for PCI.
目的观察应用重组组织型纤溶酶原激活剂溶栓治疗急性心肌梗死的效果。
Objective to observe the effect of recombinant tissue plasminogen activator in the treatment of acute myocardial infarction.
应用推荐